文献速递传染病防控与疫情报告免疫规划卫生政策与健康促进

男男性行为者和跨性别成人中与亲密及非亲密密切接触相关的II分支猴痘风险——美国,2022年8月至2023年7月

Risk of Clade II Mpox Associated with Intimate and Nonintimate Close Contact Among Men Who Have Sex with Men and Transgender Adults - United States, August 2022-July 2023.
PubMed 文献 · MMWR Morb Mortal Wkly Rep · 2024-10-10

该研究利用2022年8月至2023年7月多辖区疫苗有效性病例对照研究数据,分析457例病例和1030例对照中150例病例和57例对照有密切接触者。报告与猴痘患者发生无安全套接受性肛交者调整后猴痘比值比为5.4(p=0.031)。尽管疫苗高效,接种覆盖率仍低,需多层面预防。

要点

  • 与猴痘患者无安全套接受性肛交者猴痘调整比值比为5.4(p=0.031)。
  • 457例病例中150例(32.8%)、1030例对照中57例(5.5%)报告与猴痘患者有密切接触。
  • 猴痘疫苗高效但接种覆盖率仍低,多层面预防仍重要。

核心结论

  • 与猴痘患者发生无安全套接受性肛交与猴痘风险升高相关,调整比值比为5.4(p=0.031)。
  • 猴痘疫苗高度有效但接种覆盖率仍低,多层面预防方法仍重要,应包括促进疫苗接种、安全性行为 practice 和提高对猴痘持续传播的认识。

研究设计与样本

  • 多辖区疫苗有效性病例对照研究,纳入2022年8月至2023年7月收集的18-49岁自认为男男性行为者或跨性别的性活跃者数据。
  • 457例病例和1030例对照满足最低数据要求,其中150例病例(32.8%)和57例对照(5.5%)报告与猴痘患者有密切接触并纳入本分析。

主要发现

  • 在报告与猴痘患者有密切接触的参与者中,报告与猴痘患者发生无安全套接受性肛交者猴痘调整比值比为5.4(p=0.031),对照为报告与猴痘患者有密切接触但未与该人发生无安全套接受性肛交者。
  • 457例病例中150例(32.8%)报告与猴痘患者有密切接触,1030例对照中57例(5.5%)报告有密切接触。

关键数值与推荐

  • 与猴痘患者发生无安全套接受性肛交者猴痘调整比值比为5.4(p=0.031),对照为报告与猴痘患者有密切接触但未发生无安全套接受性肛交者。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A global outbreak of clade II mpox associated with sexual contact, disproportionately affecting gay, bisexual, and other men who have sex with men (MSM), has been ongoing since May 2022. Information on types of contact most associated with transmission is limited. This report used data from a multijurisdictional vaccine effectiveness case-control study of sexually active persons aged 18-49 years who identified as MSM or transgender, collected during August 2022-July 2023. Odds of mpox associated with selected types of intimate and nonintimate close contact with a person with mpox were estimated. Among 457 case-patients and 1,030 control patients who met minimum data requirements, 150 (32.8%) case-patients and 57 (5.5%) control patients reported close contact with a person with mpox and were included in this analysis. Adjusted odds of mpox were 5.4 times as high among those who reported having condomless receptive anal sex with a person with mpox, compared with participants who reported close contact with a person with mpox and no condomless receptive anal sex with that person (OR = 5.4; p = 0.031). Although the mpox vaccine is highly effective, vaccination coverage remains low; a multifaceted approach to prevention remains important and should include vaccination promotion, safer sex practices, and increasing awareness that mpox continues to circulate.

来源:MMWR Morb Mortal Wkly Rep,查看原文。版权归原作者所有。

引用

  1. Chard AN, Dalton AF, Diallo AO, et al. Risk of Clade II Mpox Associated with Intimate and Nonintimate Close Contact Among Men Who Have Sex with Men and Transgender Adults - United States, August 2022-July 2023. MMWR Morb Mortal Wkly Rep. 2024. PMID: 39388387. doi:10.15585/mmwr.mm7340a2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。